The Psychomotor Retardation, a Marker of Response to rTMS Treatment in Patients with Major Depressive Disorder?

Author(s): Thibault Deschamps, Anne Sauvaget, Samuel Bulteau, Veronique Thomas-Ollivier

Now more than ever, let us continue to develop personalized medicine to improve the remission rate for treatment resistant depressed patients. Recent findings about psychomotor retardation - a core symptom of depression - provide new insights into the predictive efficiency of personalized treatments, such as rTMS.

Full-Text | PDF

Share this